Funded Tech Companies
Tengion
Wondering who provided funding to Tengion? Private investors, Safeguard Scientifics and Johnson & Johnson Development Corporation joined the equity holders in this innovative biopharmaceutical company.
Company Overview
Company Name
Tengion
Company Status
Publicly-held
Industry
Funding Rounds
Total Funding
Contact Information
Mailing Address
3929 Westpoint Blvd. G
Winston-Salem, NC 27103
USA
Winston-Salem, NC 27103
USA
Phone
Website
Email Address
Company Background Information
Overview
Tengion (NASDAQ: TNGN) is a leader in developing autologous neo-organs and tissues, such as bladders, that are derived from the patient's own (autologous) cells.
Profile
Social Media
Company News
Facebook
YouTube
Last Transaction
9/24/2012
Financing History
Date
Type
Amount
Management Team
Title
Name
Email & Social
Chief Executive Officer
John Miclot
Chief Financial Officer
Brian Davis
Chief Scientific Officer
Tim Bertram
Chief Technical Officer
Deepak Jain
Company Investors
- Safeguard Scientifics (Peter Boni)
- Johnson & Johnson Development Corporation
- Deerfield Capital
- Oak Investment Partners
- Healthcap Venture Capital
- L Capital Partners
- Quaker Partners (Ira Lubert)
- Bain Capital Ventures
- Johnson & Johnson Development Corporation (David Holveck)
- Deerfield Capital (Howard Furst)
- Quaker Partners (Brenda Gavin)
- Bain Capital Ventures (James Nahirny)
- Oxford Finance
- Horizon Technology Finance
- Healthcap Venture Capital (Carl-Johan Dalsgaard)
Browse more funded tech companies:
Share this article
About Our VC & M&A Database
This tech company profile is powered by VentureDeal.com, a leading provider of venture capital transaction data.
Additional Resources for Entrepreneurs